BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22105228)

  • 1. Antagonistic effects of selenium and lipid peroxides on growth control in early hepatocellular carcinoma.
    Rohr-Udilova N; Sieghart W; Eferl R; Stoiber D; Björkhem-Bergman L; Eriksson LC; Stolze K; Hayden H; Keppler B; Sagmeister S; Grasl-Kraupp B; Schulte-Hermann R; Peck-Radosavljevic M
    Hepatology; 2012 Apr; 55(4):1112-21. PubMed ID: 22105228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma.
    Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY
    Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver.
    El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N
    Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serine 727 phosphorylation of STAT3: an early change in mouse hepatocarcinogenesis induced by neonatal treatment with diethylnitrosamine.
    Miyakoshi M; Yamamoto M; Tanaka H; Ogawa K
    Mol Carcinog; 2014 Jan; 53(1):67-76. PubMed ID: 22911886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid hydroperoxides from processed dietary oils enhance growth of hepatocarcinoma cells.
    Rohr-Udilova NV; Stolze K; Sagmeister S; Nohl H; Schulte-Hermann R; Grasl-Kraupp B
    Mol Nutr Food Res; 2008 Mar; 52(3):352-9. PubMed ID: 18293301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of AP-1 interference induced by TAC-101 to tumor growth suppression in a hepatocellular carcinoma model.
    Eshima K; Fukaya S; Sugimoto A; Mori T; Yokoi H; Yamamoto Y; Sugiura S; Honda S; Masuko N; Murakami K; Yamasaki Y; Kagechika H
    Tumour Biol; 2009; 30(1):1-7. PubMed ID: 19142034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein docosahexaenoic acid nanoparticles induce ferroptotic cell death in hepatocellular carcinoma.
    Ou W; Mulik RS; Anwar A; McDonald JG; He X; Corbin IR
    Free Radic Biol Med; 2017 Nov; 112():597-607. PubMed ID: 28893626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Nasr M; Selima E; Hamed O; Kazem A
    Eur J Pharmacol; 2014 Jan; 723():267-75. PubMed ID: 24291100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 inhibits cell proliferation in a rat model of hepatocellular carcinoma.
    Moran DM; Mayes N; Koniaris LG; Cahill PA; McKillop IH
    Liver Int; 2005 Apr; 25(2):445-57. PubMed ID: 15780071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
    Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
    J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rac activation is associated with hepatocellular carcinoma metastasis by up-regulation of vascular endothelial growth factor expression.
    Lee TK; Poon RT; Yuen AP; Man K; Yang ZF; Guan XY; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5082-9. PubMed ID: 16951224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor in human hepatocellular carcinoma.
    Yamaguchi R; Yano H; Iemura A; Ogasawara S; Haramaki M; Kojiro M
    Hepatology; 1998 Jul; 28(1):68-77. PubMed ID: 9657098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
    Wang RY; Chen L; Chen HY; Hu L; Li L; Sun HY; Jiang F; Zhao J; Liu GM; Tang J; Chen CY; Yang YC; Chang YX; Liu H; Zhang J; Yang Y; Huang G; Shen F; Wu MC; Zhou WP; Wang HY
    Gastroenterology; 2013 Dec; 145(6):1436-48.e1-12. PubMed ID: 23933603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mybl2 expression is under genetic control and contributes to determine a hepatocellular carcinoma susceptible phenotype.
    Frau M; Ladu S; Calvisi DF; Simile MM; Bonelli P; Daino L; Tomasi ML; Seddaiu MA; Feo F; Pascale RM
    J Hepatol; 2011 Jul; 55(1):111-9. PubMed ID: 21419759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive Notch2 signaling induces hepatic tumors in mice.
    Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
    Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
    Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
    Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
    Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
    J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.